CIPLA's weekly performance was disappointing, with a return of -1.25% and a Sharpe Ratio of -0.49, indicating poor risk-adjusted returns. The stock's volatility was moderate at 10.18%, but its Max Drawdown of -1.25% suggests that it was a relatively risky investment this week. Compared to its peers, CIPLA outperformed GRASIM and DIVISLAB but underperformed SUNPHARMA. Overall, CIPLA's weekly performance was lackluster and accompanied by moderate risk.

[Volatility: 10.18%]